You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

All-trans retinoic acid

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

the Lung Complication of COVID-19 Trial (Aerosolized All-Trans Retinoic acid plus oral Tamoxifen, Standard treatment)

Unknown status
  • the Lung Complication of COVID-19
  • Aerosolized All-Trans Retinoic acid plus oral Tamoxifen
  • Standard treatment
  • (no location specified)
Oct 23, 2020

Solid Tumors and Hematologic Malignancy Trial in Belgium, Netherlands, United States (INCB059872, all-trans retinoic acid

Terminated
  • Solid Tumors and Hematologic Malignancy
  • Birmingham, Alabama
  • +14 more
Jun 29, 2022

Immune Thrombocytopenia Trial in Beijing (all trans retinoic acid)

Unknown status
  • Immune Thrombocytopenia
  • all trans retinoic acid
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Oct 31, 2020

Immune Thrombocytopenia Trial in Beijing (Rituximab, All-trans retinoic acid)

Active, not recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
  • +3 more
Jan 16, 2021

Acute Promyelocytic Leukemia Trial in Bari, Pavia, Roma (all-trans retinoic acid (ATRA))

Recruiting
  • Acute Promyelocytic Leukemia
  • all-trans retinoic acid (ATRA)
  • Bari, Italy
  • +2 more
Oct 12, 2020

Acute Myeloid Leukemia Trial in Regensburg (low-dose Azacitidine, Pioglitazone, ATRA)

Terminated
  • Acute Myeloid Leukemia
  • low-dose Azacitidine
  • +3 more
  • Regensburg, Germany
    University Hospital Regensburg
Nov 3, 2020

Autoimmune Anemia Trial in Beijing (sirolimus and ATRA)

Not yet recruiting
  • Autoimmune Anemia
  • sirolimus and ATRA
  • Beijing, China
    Peking union medical college hospital
Mar 25, 2020

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

Small Cell Lung Cancer Trial in Tampa (Paclitaxel, Drug: Ad.p53-DC vaccines, All -trans Retinoic Acid (ATRA))

Completed
Has Results
  • Small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Nov 6, 2019

Acute Myeloid Leukemia Trial in Austria, Germany (Gemtuzumab Ozogamicin (Mylotarg), standard chemo)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin (Mylotarg)
  • standard chemotherapy
  • Graz, Austria
  • +59 more
Sep 28, 2021

Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +5 more
  • Innsbruck, Austria
  • +109 more
Oct 10, 2022

AML Trial in Tianjin (Cytarabine, all-trans retinoic acid, Arsenic Trioxide)

Recruiting
  • AML
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 19, 2020

Acute Promyelocytic Leukemia Trial in Houston (All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), Idarubicin)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • All-Trans Retinoic Acid (ATRA)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2019

Breast Tumor Female Trial in Bergamo (all-trans retinoic acid, Anastrozole 1mg)

Unknown status
  • Breast Neoplasm Female
  • all-trans retinoic acid
  • Anastrozole 1mg
  • Bergamo, Italy
    ASST Papa Giovanni XXIII
Oct 3, 2019

Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)

Recruiting
  • Solid Tumor, Adult
  • HF1K16 /Arm 45 mg/m2
  • +3 more
  • Shanghai, Shanghai, China
  • +2 more
May 23, 2022

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Acne Vulgaris Trial in Dripping Springs, Pflugerville (Isotretinoin, Amzeeq 4% Topical Foam)

    Active, not recruiting
    • Acne Vulgaris
    • Dripping Springs, Texas
    • +1 more
    Mar 22, 2022

    MDS Trial in Saint-Petersburg (Nivolumab, Azacitidine, Fludarabine)

    Terminated
    • Myelodysplastic Syndromes
    • Saint-Petersburg, Russian Federation
      First Pavlov State Medical University of St. Petersburg
    Apr 3, 2019

    Leukemia Trial in Worldwide (all-trans retinoic acid (ATRA))

    Recruiting
    • Leukemia
    • all-trans retinoic acid (ATRA)
    • Antwerpen, Belgium
    • +79 more
    Oct 12, 2020

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +28 more
    Jan 25, 2023

    Non-melanoma Skin Cancer Trial in Birmingham (UAB30, Placebo)

    Recruiting
    • Non-melanoma Skin Cancer
    • Birmingham, Alabama
      UAB Dermatology
    Aug 30, 2022

    Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +4 more
    • Los Angeles, California
    • +34 more
    Jan 25, 2023

    MDS Trial (Roxadustat in combination with retinoic acid)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Roxadustat in combination with retinoic acid
    • (no location specified)
    Aug 26, 2023

    Covid19 Vaccine Trial (drug, combination product, biological)

    Not yet recruiting
    • Covid19 Vaccine
    • Oral 13 cis retinoic acid
    • +4 more
    • (no location specified)
    May 28, 2021

    Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, Pembrolizumab/Quavonlimab)

    Recruiting
    • Melanoma
    • Pembrolizumab
    • +5 more
    • Los Angeles, California
    • +39 more
    Jan 25, 2023